Dennis Mynarcik's Contact Details

Dennis Mynarcik's Company Details

Pontis Biologics, Inc.

Huntington, New York, United States • 1 Employees
Research

Pontis Biologics was founded in 2018. We set out to develop an at home oral hygiene product worthy of the 21st century. Pontis' focus was a model based on the constituents of the oral environment: oral microbiome, saliva components and oral epithelial products. These facts, combined with fundamental principles of biochemistry and biophysics, were used to formulate a new model of tartar formation. Pontis has data demonstrating that the formulation is completely safe, affordable and effective at eliminating, not just reducing, tartar/calculus. The formulation (Tartarase) can enter the marketplace as a cosmetic with FDA oversight limited to assessing safety. Founder Dennis Mynarcik has a pending composition of matter patent in the US and internationally, wholly owned by Pontis. We have excellent pre-clinical data and are preparing for human clinical trials with a company recognized and respected by the American Dental Association. Pontis is seeking to establish a partnership with an established healthcare/pharma company to formulate, market, and distribute the dentifrice worldwide.